Grant: Team Grant: Physical Activity, Mobility and Health (LOI)
University of Alberta
$10,000.00
Sarcopenia: prevalence, implications & treatment in patients with cancer
EF 2008-09
Résumé
Sarcopenia is a recently coined term denoting a reduced quantity of skeletal muscle. Our understanding of the consequences of sarcopenia has been advanced by the emergence of high precision approaches for assessing specific features of skeletal muscles. Sarcopenia is reported to associate with significant risks of physical disability, falls, fractures, frailty, extended stay in hospital, infectious and non-infectious complications in hospitalized patients as well as overall mortality. We have recently shown that sarcopenia is common in cancer patients, and that this is associated with elevated risk of being partially or entirely bedridden, increased risk for severe toxicity during cancer treatment as well as shortened survival. This new evidence suggests that sarcopenia is a common and important factor relating to physical function, mobility and diverse health outcomes in cancer patients. The intention of our new research program is to define the prevalence, health risks and treatments to prevent or reverse sarcopenia in these patients, with a view to improving treatment response to the primary cancer therapy, and increasing independence, physical function and quality of life.
Programme
Team Grant: Physical Activity, Mobility and Health (LOI)
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
181607
Name
Baracos Vickie E
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Musculoskeletal Health and Arthritis
Theme2
Clinical
Prcname2
Team Grant: Physical Activity, Mobility and Health
Projecttitle
Sarcopenia: prevalence, implications & treatment in patients with cancer
Programtype2
Operating Grants
Orgnameinp2
University of Alberta
Cihramount2
$10,000
Cihrequipment2
$0
Programname2
Team Grant: Physical Activity, Mobility and Health (LOI)
Keyworddelim
Cancer; Mobility; Sarcopenia; Skeletal Muscle
Abstract
Sarcopenia is a recently coined term denoting a reduced quantity of skeletal muscle. Our understanding of the consequences of sarcopenia has been advanced by the emergence of high precision approaches for assessing specific features of skeletal muscles. Sarcopenia is reported to associate with significant risks of physical disability, falls, fractures, frailty, extended stay in hospital, infectious and non-infectious complications in hospitalized patients as well as overall mortality. We have recently shown that sarcopenia is common in cancer patients, and that this is associated with elevated risk of being partially or entirely bedridden, increased risk for severe toxicity during cancer treatment as well as shortened survival. This new evidence suggests that sarcopenia is a common and important factor relating to physical function, mobility and diverse health outcomes in cancer patients. The intention of our new research program is to define the prevalence, health risks and treatments to prevent or reverse sarcopenia in these patients, with a view to improving treatment response to the primary cancer therapy, and increasing independence, physical function and quality of life.
Competitiondate
200901
Approvedterm2
1 yr 0 mth
Pinamesdelim
Baracos, Vickie E
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $10,000~ $0~